All Stories

  1. Redefining Chemotherapy-Related Headaches: From Pathobiology to Differential Diagnosis and Management

    Article • International Journal of Molecular Sciences, December 2025, MDPI AG

    Professor Stergios Boussios

  2. Cancer Reversion Therapy: Prospects, Progress and Future Directions

    Article • Current Issues in Molecular Biology, December 2025, MDPI AG

    Professor Stergios Boussios

  3. Molecular engines driving biogenesis, trafficking and release of exosomes: SNARE proteins

    Article • Extracellular Vesicle, December 2025, Elsevier

    Professor Stergios Boussios

  4. The risk of lung cancer from vaping or e-cigarette usage: a systematic review

    Article • ESMO Open, December 2025, Elsevier

    Professor Stergios Boussios

  5. Fatal Myocarditis Following Adjuvant Immunotherapy: A Case Report and Literature Review

    Article • International Journal of Molecular Sciences, December 2025, MDPI AG

    Professor Stergios Boussios

  6. SKP2 at the crossroads of proliferation and immune evasion: a new target in the tumor microenvironment

    Article • Precision Clinical Medicine, October 2025, Oxford University Press (OUP)

    Professor Stergios Boussios

  7. Smart Nanomedicines for Neurodegenerative Diseases: Empowering New Therapies with Molecular Imaging and Artificial Intelligence

    Article • Molecular Diagnosis & Therapy, October 2025, Springer Science + Business Media

    Professor Stergios Boussios

  8. Enhancing home rehabilitation through AI-driven virtual assistants: a narrative review

    Article • Annals of Translational Medicine, October 2025, AME Publishing Company

    Professor Stergios Boussios

  9. Generative artificial intelligence in predictive analysis of diabetes and its complications: a narrative review

    Article • Annals of Translational Medicine, October 2025, AME Publishing Company

    Professor Stergios Boussios

  10. Smart emergency care: a narrative review of predictive machine learning models

    Article • Annals of Translational Medicine, October 2025, AME Publishing Company

    Professor Stergios Boussios

  11. Comparative Analysis of Large Language Models in Dermatological Diagnosis: An Evaluation of Diagnostic Accuracy

    Article • Cureus, September 2025, Springer Science + Business Media

    Professor Stergios Boussios

  12. The evolution of targeted intra operative radiotherapy in early breast cancer

    Article • Journal of Cancer Research and Clinical Oncology, September 2025, Springer Science + Business Media

    Professor Stergios Boussios

  13. The landscape of conventional and artificial intelligence-based clinical prediction models in non-small-cell lung cancer: from development to real-world validation

    Article • ESMO Open, September 2025, Elsevier

    Professor Stergios Boussios

  14. Agnostic Biomarkers and Molecular Signatures in Colorectal Cancer—Guiding Chemotherapy and Predicting Response

    Article • Biomedicines, August 2025, MDPI AG

    Professor Stergios Boussios

  15. Immune Organoids: A Review of Their Applications in Cancer and Autoimmune Disease Immunotherapy

    Article • Current Issues in Molecular Biology, August 2025, MDPI AG

    Professor Stergios Boussios

  16. Metformin for patients with metastatic prostate cancer starting androgen deprivation therapy: a randomised phase 3 trial of the STAMPEDE platform protocol

    Article • The Lancet Oncology, August 2025, Elsevier

    Professor Stergios Boussios

  17. Enhancing Parkinson’s disease prediction using meta-heuristic optimized machine learning models

    Article • Personalized Medicine, July 2025, Taylor & Francis

    Professor Stergios Boussios

  18. Evaluating AI adoption in healthcare: Insights from the information governance professionals in the United Kingdom

    Article • International Journal of Medical Informatics, July 2025, Elsevier

    Professor Stergios Boussios

  19. The Impact of AI-Driven Chatbot Assistance on Protocol Development and Clinical Research Engagement: An Implementation Report

    Article • Journal of Personalized Medicine, June 2025, MDPI AG

    Professor Stergios Boussios

  20. Stacked Ensemble Learning for Classification of Parkinson’s Disease Using Telemonitoring Vocal Features

    Article • Diagnostics, June 2025, MDPI AG

    Professor Stergios Boussios

  21. Urban Microclimates and Their Relationship with Social Isolation: A Review

    Article • International Journal of Environmental Research and Public Health, June 2025, MDPI AG

    Professor Stergios Boussios

  22. Molecularly directed therapy in cancers of unknown primary: A systematic review and meta-analysis

    Article • European Journal of Cancer, June 2025, Elsevier

    Professor Stergios Boussios

  23. Pathobiology and Molecular Pathways Implicated in Osteosarcoma Lung Metastasis: A Scoping Review

    Article • Technology in Cancer Research & Treatment, June 2025, SAGE Publications

    Professor Stergios Boussios

  24. Reversing Epigenetic Dysregulation in Neurodegenerative Diseases: Mechanistic and Therapeutic Considerations

    Article • International Journal of Molecular Sciences, May 2025, MDPI AG

    Professor Stergios Boussios

  25. Disentangling the Gordian Knot of parasympathetic innervations in arthritic joint

    Article • Neuroscience, May 2025, Elsevier

    Professor Stergios Boussios

  26. AI-Driven Advancements in Orthodontics for Precision and Patient Outcomes

    Article • Dentistry Journal, April 2025, MDPI AG

    Professor Stergios Boussios

  27. The current landscape of artificial intelligence in computational histopathology for cancer diagnosis

    Article • Discover Oncology, April 2025, Springer Science + Business Media

    Professor Stergios Boussios

  28. Plasma AR Alterations and Timing of Intensified Hormone Treatment for Prostate Cancer

    Article • JAMA Oncology, April 2025, American Medical Association (AMA)

    Professor Stergios Boussios

  29. Intracellular and extracellular activities of V-domain Ig-containing suppressor of T cell activation (VISTA) modulated by immunosuppressive factors of tumour microenvironment

    Article • Cancer Letters, April 2025, Elsevier

    Professor Stergios Boussios

  30. AI-Driven Advances in Low-Dose Imaging and Enhancement—A Review

    Article • Diagnostics, March 2025, MDPI AG

    Professor Stergios Boussios

  31. Spinal MRI in Patients with Suspected Metastatic Spinal Cord Compression: A Quality Improvement Audit in a District General Hospital in Kent, UK

    Article • International Journal of Environmental Research and Public Health, March 2025, MDPI AG

    Professor Stergios Boussios

  32. Diagnosis and Treatment of Gestational Non-Epithelial Ovarian Cancer: A Systematic Review

    Article • Anticancer Research, March 2025, International Institute of Anticancer Research

    Professor Stergios Boussios

  33. Male Breast Cancer: A Single Institutional Clinicopathological Profiling

    Article • Anticancer Research, March 2025, International Institute of Anticancer Research

    Professor Stergios Boussios

  34. Enhancing Ophthalmic Diagnosis and Treatment with Artificial Intelligence

    Article • Medicina, February 2025, MDPI AG

    Professor Stergios Boussios

  35. Precision oncology through next generation sequencing in hepatocellular carcinoma

    Article • Heliyon, February 2025, Elsevier

    Professor Stergios Boussios

  36. Spotlight on Lung Cancer Disparities in India

    Article • JCO Global Oncology, February 2025, American Society of Clinical Oncology (ASCO)

    Professor Stergios Boussios

  37. Molecular biomarkers of glial activation and injury in epilepsy

    Article • Drug Discovery Today, February 2025, Elsevier

    Professor Stergios Boussios

  38. Integrating AI into Cancer Immunotherapy—A Narrative Review of Current Applications and Future Directions

    Article • Diseases, January 2025, MDPI AG

    Professor Stergios Boussios

  39. Exosomal Liquid Biopsy in Prostate Cancer: A Systematic Review of Biomarkers for Diagnosis, Prognosis, and Treatment Response

    Article • International Journal of Molecular Sciences, January 2025, MDPI AG

    Professor Stergios Boussios

  40. Molecular Biology of Cancer—Interplay of Malignant Cells with Emerging Therapies

    Article • International Journal of Molecular Sciences, December 2024, MDPI AG

    Professor Stergios Boussios

  41. Construction of a prognostic survival model with tumor immune-related genes for breast cancer

    Article • Translational Cancer Research, December 2024, AME Publishing Company

    Professor Stergios Boussios

  42. An overview of immune checkpoint inhibitor toxicities in bladder cancer

    Article • Toxicology Reports, December 2024, Elsevier

    Professor Stergios Boussios

  43. An orthogonal approach for analysis of underivatized steroid hormones using ultrahigh performance supercritical fluid chromatography-mass spectrometry (UHPSFC-MS)

    Article • Acta Neurovegetativa, November 2024, Springer Science + Business Media

    Professor Stergios Boussios

  44. AI-Guided Cancer Therapy for Patients with Coexisting Migraines

    Article • Cancers, October 2024, MDPI AG

    Professor Stergios Boussios

  45. Artificial Intelligence – Guided Cancer Therapy for Patients with Migraine Comorbidities

    Article • October 2024, MDPI AG

    Professor Stergios Boussios

  46. Early adoption of innovation in HPV prevention strategies: closing the gap in cervical cancer

    Article • ecancermedicalscience, September 2024, Cancer Intelligence

    Professor Stergios Boussios

  47. Paediatric Anatomical Models in Radiotherapy Applications

    Article • Clinical Oncology, September 2024, Elsevier

    Professor Stergios Boussios

  48. Applying whole-genome and whole-exome sequencing in breast cancer: a review of the landscape

    Article • Breast Cancer, August 2024, Springer Science + Business Media

    Professor Stergios Boussios

  49. Belzutifan versus Everolimus for Advanced Renal-Cell Carcinoma

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, August 2024, New England Journal of Medicine (NEJM/MMS)

    Professor Stergios Boussios

  50. Antibody Drug Conjugates in Urological Cancers: A Review of the Current Landscape

    Article • Current Oncology Reports, April 2024, Springer Science + Business Media

    Professor Stergios Boussios

  51. lncRNA Biomarkers of Glioblastoma Multiforme

    Article • Biomedicines, April 2024, MDPI AG

    Professor Stergios Boussios

  52. Large Language Models in Oncology: Revolution or Cause for Concern?

    Article • Current Oncology, March 2024, MDPI AG

    Professor Stergios Boussios

  53. The Application of Radiomics and AI to Molecular Imaging for Prostate Cancer

    Article • Journal of Personalized Medicine, March 2024, MDPI AG

    Professor Stergios Boussios

  54. A novel PD-1/PD-L1 pathway-related seven-gene signature for the development and validation of the prognosis prediction model for breast cancer

    Article • Translational Cancer Research, March 2024, AME Publishing Company

    Professor Stergios Boussios

  55. A rare case of metaplastic breast carcinoma from India: Towards precision oncology

    Article • Cancer Reports, February 2024, Wiley

    Professor Stergios Boussios

  56. Immunotherapy Combined With Standard Therapies in Head and Neck Squamous Cell Carcinoma – A Meta-analysis

    Article • Anticancer Research, February 2024, International Institute of Anticancer Research

    Professor Stergios Boussios

  57. Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4

    Article • Therapeutic Advances in Medical Oncology, January 2024, SAGE Publications

    Professor Stergios Boussios

  58. Exosomes in Renal Cell Cancer: Diagnostic and Therapeutic Nanovehicles

    Article • Technology in Cancer Research & Treatment, January 2024, SAGE Publications

    Professor Stergios Boussios

  59. Stage 3 N2 Lung Cancer: A Multidisciplinary Therapeutic Conundrum

    Article • Current Oncology Reports, January 2024, Springer Science + Business Media

    Professor Stergios Boussios

  60. Medical oncology: challenges in 2022

    Article • Annals of Palliative Medicine, January 2024, AME Publishing Company

    Professor Stergios Boussios

  61. Frontiers of Molecular Biology of Cancer

    Article • International Journal of Molecular Sciences, December 2023, MDPI AG

    Professor Stergios Boussios

  62. Immune checkpoint inhibitors in patients with cancers of unknown primary

    Article • European Journal of Cancer, December 2023, Elsevier

    Professor Stergios Boussios

  63. Astragaloside IV enhances the sensitivity of breast cancer stem cells to paclitaxel by inhibiting stemness

    Article • Translational Cancer Research, December 2023, AME Publishing Company

    Professor Stergios Boussios

  64. Frontiers of Ovarian Carcinosarcoma

    Article • Current Treatment Options in Oncology, November 2023, Springer Science + Business Media

    Professor Stergios Boussios

  65. COVID-19 Associated Mucormycosis and Cytomegalovirus Infection – A Case Report

    Article • November 2023, MDPI AG

    Professor Stergios Boussios

  66. Renal Cell Cancer – Insights in Drug Resistance Mechanisms

    Article • Anticancer Research, November 2023, International Institute of Anticancer Research

    Professor Stergios Boussios

  67. The integration of palliative care with oncology: the path ahead

    Article • Annals of Palliative Medicine, November 2023, AME Publishing Company

    Professor Stergios Boussios

  68. Cardiac Toxicities in Oncology: Elucidating the Dark Box in the Era of Precision Medicine

    Article • Current Issues in Molecular Biology, October 2023, MDPI AG

    Professor Stergios Boussios

  69. Exosomes in the Diagnosis and Treatment of Renal Cell Cancer

    Article • International Journal of Molecular Sciences, September 2023, MDPI AG

    Professor Stergios Boussios

  70. Prognostic Factors in Patients with Metastatic Spinal Cord Compression Secondary to Lung Cancer—A Retrospective UK Single-Centre Study

    Article • Cancers, September 2023, MDPI AG

    Professor Stergios Boussios

  71. Gestational Renal Cell Cancer – An Update

    Article • Anticancer Research, August 2023, International Institute of Anticancer Research

    Professor Stergios Boussios

  72. Hallmarks of the Tumour Microenvironment of Gliomas and Its Interaction with Emerging Immunotherapy Modalities

    Article • International Journal of Molecular Sciences, August 2023, MDPI AG

    Professor Stergios Boussios

  73. Re: Pain and Health-related Quality of Life with Olaparib Versus Physician’s Choice of Next-generation Hormonal Drug in Patients with Metastatic Castration-resistant Prostate Cancer with Homologous Recombination Repair Gene Alterations (PROfound): An O...

    Article • European Urology, August 2023, Elsevier

    Professor Stergios Boussios

  74. Prognostic Factors in Patients with Metastatic Spinal Cord Compression Secondary to Lung Cancer – a Retrospective UK Single-Center Study

    Article • July 2023, MDPI AG

    Professor Stergios Boussios

  75. Emerging Hallmarks of the Tumour Microenvironment of Gliomas and the Interplay with Immunotherapy

    Article • July 2023, MDPI AG

    Professor Stergios Boussios

  76. Advances in Ovarian Cancer Treatment Beyond PARP Inhibitors

    Article • Current Cancer Drug Targets, July 2023, Bentham Science Publishers

    Professor Stergios Boussios

  77. Advances in adoptive T-cell therapy for metastatic melanoma

    Article • Current Research in Translational Medicine, July 2023, Elsevier

    Professor Stergios Boussios

  78. Clinical Challenges in the Management of Malignant Ovarian Germ Cell Tumours

    Article • International Journal of Environmental Research and Public Health, June 2023, MDPI AG

    Professor Stergios Boussios

  79. Impact of COVID-19 on cancer services and patients’ outcomes: a retrospective single-center study

    Article • Annals of Translational Medicine, June 2023, AME Publishing Company

    Professor Stergios Boussios

  80. State-of-the-Art Molecular Oncology in UK

    Article • International Journal of Molecular Sciences, May 2023, MDPI AG

    Professor Stergios Boussios

  81. Posterior Reversible Encephalopathy Syndrome after Pazopanib Therapy

    Article • Diseases, May 2023, MDPI AG

    Professor Stergios Boussios

  82. Clinico-Pathological Factors Determining Recurrence of Phyllodes Tumors of the Breast: The 25-Year Experience at a Tertiary Cancer Centre

    Article • Journal of Personalized Medicine, May 2023, MDPI AG

    Professor Stergios Boussios

  83. Abiraterone acetate plus prednisolone with or without enzalutamide for patients with metastatic prostate cancer starting androgen deprivation therapy: final results from two randomised phase 3 trials of the STAMPEDE platform protocol

    Article • The Lancet Oncology, May 2023, Elsevier

    Professor Stergios Boussios

  84. Prostate cancer—what about oligometastatic disease and stereotactic ablative radiotherapy?—a narrative review

    Article • Annals of Palliative Medicine, May 2023, AME Publishing Company

    Professor Stergios Boussios

  85. From Biology to Diagnosis and Treatment: The Ariadne’s Thread in Cancer of Unknown Primary

    Article • International Journal of Molecular Sciences, March 2023, MDPI AG

    Professor Stergios Boussios

  86. Constrictive Pericarditis–A Cloak Camouflaging Lymphoma

    Article • Hematology Reports, March 2023, MDPI AG

    Professor Stergios Boussios

  87. Temporary treatment cessation versus continuation of first-line tyrosine kinase inhibitor in patients with advanced clear cell renal cell carcinoma (STAR): an open-label, non-inferiority, randomised, controlled, phase 2/3 trial

    Article • The Lancet Oncology, March 2023, Elsevier

    Professor Stergios Boussios

  88. Aberrations of DNA Repair Pathways in Prostate Cancer—The State of the Art

    Article • International Journal of Molecular Sciences, February 2023, MDPI AG

    Professor Stergios Boussios

  89. HPV and Cervical Cancer: A Review of Epidemiology and Screening Uptake in the UK

    Article • Pathogens, February 2023, MDPI AG

    Professor Stergios Boussios

  90. Predictive biomarkers for immune checkpoint inhibitor response in urothelial cancer

    Article • Therapeutic Advances in Medical Oncology, January 2023, SAGE Publications

    Professor Stergios Boussios

  91. Efficacy and Safety of COVID-19 Vaccines—An Update

    Article • Diseases, November 2022, MDPI AG

    Professor Stergios Boussios

  92. A Primary Mediastinal Monophasic Spindle-Cell Synovial Sarcoma with Superior Venacaval Obstruction

    Article • Diseases, November 2022, MDPI AG

    Professor Stergios Boussios

  93. Hereditary Ovarian Cancer: Towards a Cost-Effective Prevention Strategy

    Article • International Journal of Environmental Research and Public Health, September 2022, MDPI AG

    Professor Stergios Boussios

  94. Surgery for T4 Colorectal Cancer in Older Patients: Determinants of Outcomes

    Article • Journal of Personalized Medicine, September 2022, MDPI AG

    Professor Stergios Boussios

  95. Chromosomal instability in cancers of unknown primary

    Article • European Journal of Cancer, September 2022, Elsevier

    Professor Stergios Boussios

  96. BRCA Mutations in Ovarian and Prostate Cancer: Bench to Bedside

    Article • Cancers, August 2022, MDPI AG

    Professor Stergios Boussios

  97. Recent Insights into PARP and Immuno-Checkpoint Inhibitors in Epithelial Ovarian Cancer

    Article • International Journal of Environmental Research and Public Health, July 2022, MDPI AG

    Professor Stergios Boussios

  98. COVID-19, Mucormycosis and Cancer: The Triple Threat—Hypothesis or Reality?

    Article • Journal of Personalized Medicine, July 2022, MDPI AG

    Professor Stergios Boussios

  99. Epithelial Ovarian Cancer: Providing Evidence of Predisposition Genes

    Article • International Journal of Environmental Research and Public Health, July 2022, MDPI AG

    Professor Stergios Boussios

  100. Microsatellite instability testing in colorectal patients with Lynch syndrome: lessons learned from a case report and how to avoid such pitfalls

    Article • Personalized Medicine, July 2022, Future Medicine

    Professor Stergios Boussios

  101. Sarcoma of unknown primary: myth or reality?

    Article • Journal of the Egyptian National Cancer Institute, June 2022, Springer Science + Business Media

    Professor Stergios Boussios

  102. Systematic review of the CUP trials characteristics and perspectives for next-generation studies

    Article • Cancer Treatment Reviews, June 2022, Elsevier

    Professor Stergios Boussios

  103. Applications of Proteomics in Ovarian Cancer: Dawn of a New Era

    Article • Proteomes, May 2022, MDPI AG

    Professor Stergios Boussios

  104. Androgen Receptor Gene Pathway Upregulation and Radiation Resistance in Oligometastatic Prostate Cancer

    Article • International Journal of Molecular Sciences, April 2022, MDPI AG

    Professor Stergios Boussios

  105. Epilepsy and Diagnostic Dilemmas: The Role of Language and Speech-Related Seizures

    Article • Journal of Personalized Medicine, April 2022, MDPI AG

    Professor Stergios Boussios

  106. Metastatic Anorectal Melanoma Presenting as Seizures: An Infrequent Culprit

    Article • Diseases, April 2022, MDPI AG

    Professor Stergios Boussios

  107. Case of cerebral venous thrombosis on a patient with background of nephrotic syndrome

    Article • BMJ Case Reports, March 2022, BMJ

    Professor Stergios Boussios

  108. Systematic review of fetal and placental metastases among pregnant patients with cancer

    Article • Cancer Treatment Reviews, March 2022, Elsevier

    Professor Stergios Boussios

  109. Non-Epithelial Ovarian Cancers: How Much Do We Really Know?

    Article • International Journal of Environmental Research and Public Health, January 2022, MDPI AG

    Professor Stergios Boussios

  110. Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol

    Article • The Lancet, January 2022, Elsevier

    Professor Stergios Boussios

  111. The outcome of patients with serous papillary peritoneal cancer, fallopian tube cancer, and epithelial ovarian cancer by treatment eras: 27 years data from the SEER registry

    Article • Cancer Epidemiology, December 2021, Elsevier

    Professor Stergios Boussios

  112. BRCA Mutations in Prostate Cancer: Assessment, Implications and Treatment Considerations

    Article • International Journal of Molecular Sciences, November 2021, MDPI AG

    Professor Stergios Boussios

  113. The Experience of a Single NHS England Trust on the Impact of the COVID-19 Pandemic on Junior and Middle-Grade Doctors: What Is Next?

    Article • International Journal of Environmental Research and Public Health, October 2021, MDPI AG

    Professor Stergios Boussios

  114. Angiogenesis and Anti-Angiogenic Treatment in Prostate Cancer: Mechanisms of Action and Molecular Targets

    Article • International Journal of Molecular Sciences, September 2021, MDPI AG

    Professor Stergios Boussios

  115. Genetic Aberrations of DNA Repair Pathways in Prostate Cancer: Translation to the Clinic

    Article • International Journal of Molecular Sciences, September 2021, MDPI AG

    Professor Stergios Boussios

  116. Unraveling the Wide Spectrum of Melanoma Biomarkers

    Article • Diagnostics, July 2021, MDPI AG

    Professor Stergios Boussios

  117. Genomic correlates of response and resistance to immune checkpoint inhibitors in carcinomas of unknown primary

    Article • European Journal of Clinical Investigation, May 2021, Wiley

    Professor Stergios Boussios

  118. Aberrations of DNA repair pathways in prostate cancer: a cornerstone of precision oncology

    Article • Expert Opinion on Therapeutic Targets, May 2021, Taylor & Francis

    Professor Stergios Boussios

  119. Cancer-Associated Thrombosis: A New Light on an Old Story

    Article • Diseases, May 2021, MDPI AG

    Professor Stergios Boussios

  120. Comparative genomic characterization of melanoma of known and unknown primary

    Article • Revista de Oncología, May 2021, Springer Science + Business Media

    Professor Stergios Boussios

  121. Immuno-oncology: a narrative review of gastrointestinal and hepatic toxicities

    Article • Annals of Translational Medicine, March 2021, AME Publishing Company

    Professor Stergios Boussios

  122. Management of Metastatic Spinal Cord Compression in Secondary Care: A Practice Reflection from Medway Maritime Hospital, Kent, UK

    Article • Journal of Personalized Medicine, February 2021, MDPI AG

    Professor Stergios Boussios

  123. Melanoma of unknown primary: New perspectives for an old story

    Article • Critical Reviews in Oncology/Hematology, February 2021, Elsevier

    Professor Stergios Boussios

  124. Current and future immunotherapy approaches in ovarian cancer

    Article • Annals of Translational Medicine, December 2020, AME Publishing Company

    Professor Stergios Boussios

  125. Development of new poly(ADP-ribose) polymerase (PARP) inhibitors in ovarian cancer: Quo Vadis?

    Article • Annals of Translational Medicine, December 2020, AME Publishing Company

    Professor Stergios Boussios

  126. Endometriosis-associated ovarian carcinomas: insights into pathogenesis, diagnostics, and therapeutic targets—a narrative review

    Article • Annals of Translational Medicine, December 2020, AME Publishing Company

    Professor Stergios Boussios

  127. Metformin and ovarian cancer: the evidence

    Article • Annals of Translational Medicine, December 2020, AME Publishing Company

    Professor Stergios Boussios

  128. NOTCH signalling in ovarian cancer angiogenesis

    Article • Annals of Translational Medicine, December 2020, AME Publishing Company

    Professor Stergios Boussios

  129. Narrative review on serous primary peritoneal carcinoma of unknown primary site: four questions to be answered

    Article • Annals of Translational Medicine, December 2020, AME Publishing Company

    Professor Stergios Boussios

  130. Neoadjuvant treatment for newly diagnosed advanced ovarian cancer: where do we stand and where are we going?

    Article • Annals of Translational Medicine, December 2020, AME Publishing Company

    Professor Stergios Boussios

  131. Ovarian cancer: state of the art and perspectives of clinical research

    Article • Annals of Translational Medicine, December 2020, AME Publishing Company

    Professor Stergios Boussios

  132. Systemic anti-cancer treatment in malignant ovarian germ cell tumours (MOGCTs): current management and promising approaches

    Article • Annals of Translational Medicine, December 2020, AME Publishing Company

    Professor Stergios Boussios

  133. Upfront debulking surgery for high-grade serous ovarian carcinoma: current evidence

    Article • Annals of Translational Medicine, December 2020, AME Publishing Company

    Professor Stergios Boussios

  134. An Update on the Prognostic and Predictive Serum Biomarkers in Metastatic Prostate Cancer

    Article • Diagnostics, July 2020, MDPI AG

    Professor Stergios Boussios

  135. Wise Management of Ovarian Cancer: On the Cutting Edge

    Article • Journal of Personalized Medicine, May 2020, MDPI AG

    Professor Stergios Boussios

  136. Poly (ADP-Ribose) Polymerase Inhibitors: Talazoparib in Ovarian Cancer and Beyond

    Article • Drugs in R&D, March 2020, Springer Science + Business Media

    Professor Stergios Boussios

  137. New rising entities in cancer of unknown primary: Is there a real therapeutic benefit?

    Article • Critical Reviews in Oncology/Hematology, March 2020, Elsevier

    Professor Stergios Boussios

  138. Veliparib in ovarian cancer: a new synthetically lethal therapeutic approach

    Article • Investigational New Drugs, October 2019, Springer Science + Business Media

    Professor Stergios Boussios

  139. Combined Strategies with Poly (ADP-Ribose) Polymerase (PARP) Inhibitors for the Treatment of Ovarian Cancer: A Literature Review

    Article • Diagnostics, August 2019, MDPI AG

    Professor Stergios Boussios

  140. PARP Inhibitors in Ovarian Cancer: The Route to “Ithaca”

    Article • Diagnostics, May 2019, MDPI AG

    Professor Stergios Boussios

  141. The Developing Story of Predictive Biomarkers in Colorectal Cancer

    Article • Journal of Personalized Medicine, February 2019, MDPI AG

    Professor Stergios Boussios

  142. Ovarian carcinosarcoma: Current developments and future perspectives

    Article • Critical Reviews in Oncology/Hematology, February 2019, Elsevier

    Professor Stergios Boussios

  143. Management of Recurrent Uterine Cervical Cancer

    Article • January 2019, Springer Science + Business Media

    Professor Stergios Boussios

  144. Spinal Ewing Sarcoma Debuting with Cord Compression: Have We Discovered the Thread of Ariadne?

    Article • Anticancer Research, October 2018, International Institute of Anticancer Research

    Professor Stergios Boussios

  145. Metastatic Spinal Cord Compression: Unraveling the Diagnostic and Therapeutic Challenges

    Article • Anticancer Research, September 2018, International Institute of Anticancer Research

    Professor Stergios Boussios

  146. A review on pregnancy complicated by ovarian epithelial and non-epithelial malignant tumors: Diagnostic and therapeutic perspectives

    Article • Journal of Advanced Research, July 2018, Elsevier

    Professor Stergios Boussios

  147. Extranodal diffuse large B-cell lymphomas: A retrospective case series and review of the literature

    Article • Hematology Reports, April 2018, MDPI AG

    Professor Stergios Boussios

  148. Malignant peritoneal mesothelioma: clinical aspects, and therapeutic perspectives

    Article • Annals of Gastroenterology, January 2018, Hellenic Society of Gastroenterology

    Professor Stergios Boussios

  149. Ovarian sex-cord stromal tumours and small cell tumours: Pathological, genetic and management aspects

    Article • Critical Reviews in Oncology/Hematology, December 2017, Elsevier

    Professor Stergios Boussios

  150. Precision medicine based on epigenomics: the paradigm of carcinoma of unknown primary

    Article • Nature Reviews Clinical Oncology, July 2017, Springer Science + Business Media

    Professor Stergios Boussios

  151. The Impact of Systemic Therapy Beyond First-line Treatment for Advanced Cervical Cancer

    Article • Clinical Oncology, March 2017, Elsevier

    Professor Stergios Boussios

  152. Dynamics of Neutrophils-to-Lymphocyte Ratio Predict Outcomes of PD-1/PD-L1 Blockade

    Article • BioMed Research International, January 2017, Hindawi Publishing Corporation

    Professor Stergios Boussios

  153. Primary Pulmonary Malignant Melanoma: Report of an Important Entity and Literature Review

    Article • Case Reports in Oncological Medicine, January 2017, Hindawi Publishing Corporation

    Professor Stergios Boussios, Chris Kyriakopoulos

  154. Current and future biomarkers in colorectal cancer

    Article • Annals of Gastroenterology, January 2017, Hellenic Society of Gastroenterology

    Professor Stergios Boussios

  155. Management of patients with recurrent/advanced cervical cancer beyond first line platinum regimens: Where do we stand? A literature review

    Article • Critical Reviews in Oncology/Hematology, December 2016, Elsevier

    Professor Stergios Boussios

  156. Non-epithelial Ovarian Cancer: Elucidating Uncommon Gynaecological Malignancies

    Article • Anticancer Research, October 2016, International Institute of Anticancer Research

    Professor Stergios Boussios

  157. Cancer specific risk in multiple sclerosis patients

    Article • Critical Reviews in Oncology/Hematology, February 2016, Elsevier

    Professor Stergios Boussios

  158. Pancreatic resection for renal cell carcinoma metastasis: An exceptionally rare coexistence

    Article • International Journal of Surgery Case Reports, January 2016, Elsevier

    Professor Stergios Boussios

  159. Bleomycin-Induced Flagellate Erythema in a Patient Diagnosed with Ovarian Yolk Sac Tumor

    Article • Case Reports in Oncological Medicine, January 2015, Hindawi Publishing Corporation

    Professor Stergios Boussios

  160. Neuroendocrine Cell Carcinoma of Unknown Primary Arising in Long Standing History of Multiple Sclerosis

    Article • Case Reports in Oncological Medicine, January 2015, Hindawi Publishing Corporation

    Professor Stergios Boussios

  161. Lung cancer in pregnancy: Report of nine cases from an international collaborative study

    Article • Lung Cancer, December 2013, Elsevier

    Professor Stergios Boussios

  162. Renal cell carcinoma in pregnancy: a rare coexistence

    Article • Revista de Oncología, September 2013, Springer Science + Business Media

    Professor Stergios Boussios